出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年6月
米国の外科手術市場 : タイプ (消化器、心臓血管、歯科、美容、泌尿器科、眼科、整形外科、耳鼻咽喉科、神経系、産科/婦人科)、チャネル (医院、病院、ASC) – 2028年までの予測
Surgical Procedures Market by Type (Gastrointestinal, Cardiovascular, Dental, Cosmetic, Urologic, Ophthalmic, Orthopedic, ENT, Nervous System, Obstetric/Gynecologic), Channel (Physician Offices, Hospitals, ASCs) – US Forecast to 2028
| ページ数 | 86 |
| 図表数 | 51 |
| 種別 | 英文調査報告書 |
| 価格 |
The US surgical procedures market is projected to reach 1,27,748.5 thousand procedures by 2028 from 1,08,275.5 thousand procedures in 2023, at a CAGR of 3.4% during the forecast period. Growth in the US surgical procedures market is mainly attributed to the rapidly ageing population leading to a higher demand for surgical interventions, the increasing prevalence of chronic diseases, and the advancements in surgical techniques propelled by technological innovations. Conversely, complications associated with surgical procedures, dearth of surgeons and surgical errors are expected to challenge market growth to a certain extent.
Ophthalmic surgical procedures segment is projected to grow at the highest CAGR during the forecast period
Based on type, the US surgical procedures market is segmented into dental, cosmetic, urologic, gastrointestinal, ENT, ophthalmic, obstetric/gynecologic, cardiovascular, orthopedic and other surgical procedures. In 2022, the dental surgical procedures segment accounted for the largest share of this market. The large share can be attributed to the increasing awareness of oral care, increasing prevalence of oral diseases, as well as rising ageing population and the associated teeth loss.
The ophthalmic surgical procedures segment is estimated to grow at the highest CAGR during the forecast period. According to the US CDC, ~12 million people 40 years and over in the US have vision impairment, including three million who have vision impairment after correction, one million who are blind, and eight million who have vision impairment due to uncorrected refractive error. The growth of the segment can be attributed to the prevalence of various ophthalmic disorders such as glaucoma, cataract, and diabetic retinopathy, especially among the geriatric population.
Ambulatory surgery centers segment is estimated to witness fastest growth during the forecast period
Based on channel, the US surgical procedures market is segmented into physician offices, hospitals, and ambulatory surgery centers. The hospitals segment is further bifurcated into inpatient and outpatient surgeries. In 2022, the physician offices segment accounted for the largest share of this market followed by hospitals and ambulatory surgery centers. The ambulatory surgery centers segment is estimated to grow at the highest CAGR during the forecast period. The preference for ASCs has risen due to numerous factors including lower costs than hospital outpatient departments (HOPDs), effective postoperative care, limited hospitalization time, limited risk of disease relapse, and faster patient recovery. A review of commercial medical claims published by the ASCA also reported that healthcare costs in the US were reduced by USD 38 billion each year due to the availability of ASCs as an alternative. The potential for cost reductions, the growing patient population, and the rising demand for better and quicker care among patients is expected to drive growth in ASCs.
Research Coverage
This report studies the US surgical procedures market based on type and channel. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. The report analyzes the US surgical procedures market and aims at estimating the surgical procedures volume and future growth potential of this market based on various segments and sub-segments.
Key Benefits of Buying the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
• Emerging Technology Analysis: Comprehensive information on the lucrative emerging technological advancements in surgical procedures
• Quantitative Analysis: Exhaustive information about number of various types of surgeries performed in the US.
目次
1 INTRODUCTION 12
1.1 STUDY OBJECTIVES 12
1.2 MARKET DEFINITION 12
1.2.1 INCLUSIONS & EXCLUSIONS 12
1.3 MARKET SCOPE 13
1.3.1 MARKETS COVERED 13
FIGURE 1 US SURGICAL PROCEDURES MARKET 13
1.3.2 YEARS CONSIDERED 13
1.4 STAKEHOLDERS 14
1.5 UNITS CONSIDERED 14
1.6 SUMMARY OF CHANGES 14
2 RESEARCH METHODOLOGY 15
2.1 RESEARCH DATA 15
2.2 RESEARCH METHODOLOGY STEPS 15
FIGURE 2 RESEARCH METHODOLOGY: US SURGICAL PROCEDURES MARKET 15
FIGURE 3 RESEARCH DESIGN 16
2.2.1 SECONDARY DATA 16
2.2.1.1 Key secondary sources 16
2.2.2 PRIMARY DATA 18
2.2.2.1 Key insights from primary sources 19
2.3 MARKET ESTIMATION 19
FIGURE 4 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 21
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 22
FIGURE 5 DATA TRIANGULATION METHODOLOGY 22
2.5 STUDY ASSUMPTIONS 23
2.6 RISK ASSESSMENT 23
TABLE 1 RISK ASSESSMENT: US SURGICAL PROCEDURES MARKET 23
2.7 LIMITATIONS 24
2.8 IMPACT OF COVID-19 ON US SURGICAL PROCEDURES MARKET 24
2.9 RECESSION IMPACT: US SURGICAL PROCEDURES MARKET 25
FIGURE 6 US HEALTHCARE INFLATION-PERCENT INCREASE 25
3 EXECUTIVE SUMMARY 26
FIGURE 7 US SURGICAL PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 26
FIGURE 8 DENTAL SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 27
FIGURE 9 ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 27
FIGURE 10 GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 28
FIGURE 11 OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 28
FIGURE 12 CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 29
FIGURE 13 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 29
FIGURE 14 COSMETIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 30
FIGURE 15 ENT SURGICAL PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 30
FIGURE 16 UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 31
FIGURE 17 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2023 VS. 2028 (THOUSAND PROCEDURES) 32
4 PREMIUM INSIGHTS 33
4.1 US SURGICAL PROCEDURES MARKET OVERVIEW 33
FIGURE 18 TECHNOLOGICAL ADVANCEMENTS IN SURGICAL PROCEDURES TO DRIVE MARKET GROWTH 33
4.2 US SURGICAL PROCEDURES MARKET, BY TYPE & CHANNEL 34
FIGURE 19 DENTAL SURGICAL PROCEDURES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 34
4.3 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE 35
FIGURE 20 INPATIENT SURGERIES TO DOMINATE MARKET OVER FORECAST PERIOD 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
FIGURE 21 US SURGICAL PROCEDURES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36
5.2.1 DRIVERS 37
5.2.1.1 Growing prevalence of cancer requiring surgical treatment 37
FIGURE 22 US: ESTIMATED NEW CASES AND DEATHS FOR EACH COMMON CANCER TYPE IN 2023 37
FIGURE 23 US: CANCER CASES, BY TYPE, 2020–2040 (THOUSANDS) 38
FIGURE 24 US: NEW CANCER CASES, 2012–2022 (MILLION INDIVIDUALS) 38
5.2.1.2 Growth in geriatric population and rise in chronic disease prevalence 39
FIGURE 25 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION) 40
5.2.1.3 Increasing rate of organ transplantation 41
TABLE 2 US: SINGLE-ORGAN TRANSPLANTS PERFORMED, 2016–2020 41
5.2.1.4 Technological advancements in surgical procedures 41
FIGURE 26 US: R&D INVESTMENTS IN MEDICAL TECHNOLOGY, 2013-2018 (MILLION) 42
5.2.2 OPPORTUNITIES 43
5.2.2.1 Increasing adoption of outpatient surgeries 43
5.2.2.2 Improved surgical techniques in bariatric procedures 43
TABLE 3 BARIATRIC SURGERIES PERFORMED, 2016–2020 44
5.2.3 CHALLENGES 44
5.2.3.1 Surgical errors 44
5.2.3.2 Complications associated with surgical procedures 45
TABLE 4 COMPLICATIONS ASSOCIATED WITH SURGICAL PROCEDURES 46
5.2.3.3 Shortage of surgeons 47
6 INDUSTRY INSIGHTS 48
6.1 INDUSTRY TRENDS 48
6.1.1 MINIMALLY INVASIVE SURGERY 48
6.1.2 INCREASING ADOPTION OF ADVANCED ROBOTICS IN ASCS 49
6.2 PRICING ANALYSIS 49
TABLE 5 TYPICAL AVERAGE COSTS FOR SOME COMMON SURGERIES 50
6.3 REIMBURSEMENT SCENARIO 51
TABLE 6 LIST OF SURGICAL PROCEDURE CODES 52
TABLE 7 COSMETIC SURGERY PROCEDURE CODES 53
6.4 TECHNOLOGY ANALYSIS 53
6.5 REGULATORY LANDSCAPE 54
7 US SURGICAL PROCEDURES MARKET, BY TYPE 55
7.1 INTRODUCTION 56
TABLE 8 US SURGICAL PROCEDURES MARKET, BY TYPE, 2021–2028 (THOUSANDS) 56
7.2 DENTAL SURGICAL PROCEDURES 57
7.2.1 RISING PREVALENCE OF ORAL DISEASES AND GROWING AWARENESS OF DENTAL CARE TO DRIVE GROWTH 57
TABLE 9 US: DENTAL SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 58
7.3 ORTHOPEDIC SURGICAL PROCEDURES 58
7.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED DEVICES TO INCREASE PROCEDURAL VOLUMES 58
TABLE 10 US: ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 59
7.4 GASTROINTESTINAL SURGICAL PROCEDURES 60
7.4.1 INCREASING NUMBER OF GASTROINTESTINAL CANCER CASES TO BOOST MARKET 60
FIGURE 27 US: STOMACH CANCER INCIDENCE, 2020–2040 (THOUSANDS) 61
TABLE 11 US: GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 61
7.5 OPHTHALMIC SURGICAL PROCEDURES 62
7.5.1 RISING PREVALENCE OF GLAUCOMA, CATARACT, AND DIABETIC RETINOPATHY TO DRIVE DEMAND FOR OPHTHALMIC SURGERY 62
TABLE 12 US: OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 63
7.6 CARDIOVASCULAR SURGICAL PROCEDURES 63
7.6.1 RISING PREVALENCE OF HEART DISEASE TO BOOST DEMAND FOR SURGERY 63
TABLE 13 US: NUMBER OF CVD CASES, 2015–2035 (MILLION) 64
TABLE 14 US: CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 65
7.7 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES 65
7.7.1 INCREASING INCIDENCE OF GYNECOLOGICAL DISEASES TO DRIVE MARKET GROWTH 65
TABLE 15 US: OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 66
7.8 COSMETIC SURGICAL PROCEDURES 67
7.8.1 ADVENT OF MINIMALLY INVASIVE SURGICAL PROCEDURES TO PROPEL ADOPTION OF COSMETIC SURGERIES 67
TABLE 16 US: COSMETIC SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 68
7.9 ENT SURGICAL PROCEDURES 68
7.9.1 RISING DISPOSABLE INCOME AND INCREASING AFFORDABILITY TO BOOST GROWTH OF ENT SURGICAL PROCEDURES 68
TABLE 17 US: ENT SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 69
7.10 UROLOGIC SURGICAL PROCEDURES 69
7.10.1 INCREASING KIDNEY DISEASE INCIDENCE TO BOOST PROCEDURAL VOLUME 69
TABLE 18 US: UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 70
7.11 OTHER SURGICAL PROCEDURES 71
TABLE 19 US: OTHER SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 71
TABLE 20 US: NERVOUS SYSTEM SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 72
TABLE 21 US: ENDOCRINE SYSTEM SURGICAL PROCEDURES, BY TYPE, 2021–2028 (THOUSANDS) 72
8 US SURGICAL PROCEDURES MARKET, BY CHANNEL 73
8.1 INTRODUCTION 74
TABLE 22 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2021–2028 (THOUSANDS) 74
8.2 PHYSICIAN OFFICES 74
8.2.1 PHYSICIAN OFFICES TO DOMINATE END-USER MARKET DUE TO TECHNOLOGICAL ADVANCES AND GROWING FEASIBILITY 74
8.3 HOSPITALS 75
TABLE 23 US: NUMBER OF REGISTERED HOSPITALS, BY NUMBER OF BEDS (2019) 75
TABLE 24 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE, 2021–2028 (THOUSANDS) 76
8.3.1 INPATIENT SURGERIES 76
8.3.1.1 Increasing incidence of cardiovascular, neurological, and intestinal disorders to drive market growth 76
8.3.2 OUTPATIENT SURGERIES 76
8.3.2.1 Convenience and lower cost to boost demand for outpatient surgeries 76
8.4 AMBULATORY SURGERY CENTERS 77
8.4.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL GROWTH 77
9 APPENDIX 79
9.1 DISCUSSION GUIDE 79
9.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 84
9.3 RELATED REPORTS 86
9.4 AUTHOR DETAILS 87